XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.350
-0.070 (-4.93%)
Nov 4, 2024, 4:00 PM EST - Market closed

XORTX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Jan '22 Dec '20 Dec '19 2018 - 2015
Market Capitalization
54122698
Upgrade
Market Cap Growth
-54.39%-63.14%-53.60%177.78%19.02%29.48%
Upgrade
Enterprise Value
2-132298
Upgrade
Last Close Price
1.352.317.2718.4512.2613.81
Upgrade
PE Ratio
--2.12-1.39-12.78-7.06-13.06
Upgrade
PB Ratio
2.020.951.701.947.35-36.66
Upgrade
P/FCF Ratio
-1.24-0.67-1.33-5.34-12.68-31.10
Upgrade
P/OCF Ratio
-1.24-0.67-1.33-5.34-12.68-31.10
Upgrade
EV/EBITDA Ratio
-0.510.16-0.33-9.46-8.40-16.46
Upgrade
EV/EBIT Ratio
-0.500.16-0.33-9.40-8.24-15.79
Upgrade
EV/FCF Ratio
-0.380.12-0.34-4.52-12.48-30.91
Upgrade
Debt / Equity Ratio
0.030.000.01---0.24
Upgrade
Debt / FCF Ratio
-0.020.00-0.01---0.20
Upgrade
Quick Ratio
7.0811.906.9626.970.180.05
Upgrade
Current Ratio
7.6613.807.2128.781.990.63
Upgrade
Return on Equity (ROE)
-29.36%-37.08%-76.43%-22.25%-245.97%-1146.60%
Upgrade
Return on Assets (ROA)
-33.14%-34.72%-38.82%-15.04%-40.80%-25.96%
Upgrade
Return on Capital (ROIC)
-40.81%-52.83%-56.97%-20.34%-125.84%-299.61%
Upgrade
Earnings Yield
-32.94%-49.17%-64.82%-6.15%-13.91%-8.11%
Upgrade
FCF Yield
-97.92%-150.08%-75.44%-18.71%-7.88%-3.22%
Upgrade
Buyback Yield / Dilution
-34.03%-33.91%-35.25%-47.77%-24.34%-1.79%
Upgrade
Total Shareholder Return
-34.03%-33.91%-35.25%-47.77%-24.34%-1.79%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.